Diabetic dyslipidemia

被引：181

作者：

Chahil, Tina J. ^{[1
]}

Ginsberg, Henry N. ^{[1
]}

机构：

[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2006年 / 35卷 / 03期

关键词：

D O I：

10.1016/j.ecl.2006.06.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 2 diabetes mellitus is associated with a markedly increased risk of cardiovascular disease. A complex dyslipidemia, which is an integral part of the underlying insulin resistance in this group, is a key to this increased risk. Increased secretion of VLDL from the liver is a central feature of dyslipidemia and is linked significantly to the low HDL and abnormal LDL that are also present. A number of physiologic and pharmacologic approaches are available and should be used aggressively to treat diabetic dyslipidemia.

引用

页码：491 / +

页数：22

共 76 条

[1] Foxo1 mediates insulin action on apoC-III and triglyceride metabolism [J].

Altomonte, J ;

Cong, L ;

Harbaran, S ;

Richter, A ;

Xu, J ;

Meseck, M ;

Dong, HJH .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (10) :1493-1503

[2]

[Anonymous], 2005, National diabetes fact sheet

[3] LDL DENSITY AND ATHEROSCLEROSIS [J].

AUSTIN, MA ;

KRAUSS, RM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (02) :115-115

[4] Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease - 10-year follow-up of the Hoorn Study [J].

Becker, A ;

Bos, G ;

de Vegt, F ;

Kostense, PJ ;

Dekker, JM ;

Nijpels, G ;

Heine, RJ ;

Bouter, LM ;

Stehouwer, CDA .

EUROPEAN HEART JOURNAL, 2003, 24 (15) :1406-1413

[5] Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].

Beckman, JA ;

Creager, MA ;

Libby, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581

[6]

Bjorkegren J, 1996, J LIPID RES, V37, P76

[7] Increased ApoB in small dense LDL particles predicts premature coronary artery disease [J].

Brunzell, JD .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) :474-475

[8] EVIDENCE FOR A COMMON, SATURABLE, TRIGLYCERIDE REMOVAL MECHANISM FOR CHYLOMICRONS AND VERY LOW-DENSITY LIPOPROTEINS IN MAN [J].

BRUNZELL, JD ;

HAZZARD, WR ;

PORTE, D ;

BIERMAN, EL .

JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) :1578-1585

[9] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].

CANNER, PL ;

BERGE, KG ;

WENGER, NK ;

STAMLER, J ;

FRIEDMAN, L ;

PRINEAS, RJ ;

FRIEDEWALD, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255

[10] Critical review of acylation-stimulating protein physiology in humans and rodents [J].

Cianflone, K ;

Xia, ZN ;

Chen, LY .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (02) :127-143

← 1 2 3 4 5 6 7 8 →